NAUT - Nautilus Biotechnology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NAUT is currently covered by 2 analysts with an average price target of $2.11. This is a potential upside of $0.89 (72.95%) from yesterday's end of day stock price of $1.22.

Nautilus Biotechnology's activity chart (see below) currently has 12 price targets and 9 ratings on display. The stock rating distribution of NAUT is 100% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 55.5 days.

Highest price target for NAUT is $3, Lowest price target is $1.75, average price target is $2.38.

Most recent stock forecast was given by TEJAS SAVANT from MORGAN STANLEY on 12-Mar-2025. First documented stock forecast 03-Aug-2021.

Best performing analysts who are covering NAUT - Nautilus Biotechnology:

Matthew Sykes Tejas Savant

Currently out of the existing stock ratings of NAUT, 1 are a SELL (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

$3

$1.78 (145.90%)

$6

7 months 15 days ago
(12-Mar-2025)

0/3 (0%)

$1.94 (183.02%)

Sell

$1.75

$0.53 (43.44%)

$3

10 months 23 days ago
(04-Dec-2024)

4/6 (66.67%)

$-0.17 (-8.85%)

111

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NAUT (Nautilus Biotechnology) average time for price targets to be met?

On average it took 55.5 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on NAUT (Nautilus Biotechnology) with a proven track record?

MATTHEW SYKES

Which analyst has the current lower performing score on NAUT (Nautilus Biotechnology) with a proven track record?

TEJAS SAVANT

Which analyst has the most public recommendations on NAUT (Nautilus Biotechnology)?

Matthew Sykes works at GOLDMAN SACHS and has 4 price targets and 5 ratings on NAUT

Which analyst is the currently most bullish on NAUT (Nautilus Biotechnology)?

Tejas Savant with highest potential upside - $1.78

Which analyst is the currently most reserved on NAUT (Nautilus Biotechnology)?

Matthew Sykes with lowest potential downside - $0.53

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?